XML 60 R46.htm IDEA: XBRL DOCUMENT v3.8.0.1
Acquisitions (Details Textual) - USD ($)
1 Months Ended 12 Months Ended
Nov. 09, 2017
Nov. 01, 2017
Apr. 21, 2017
Nov. 30, 2017
Oct. 16, 2017
Jun. 30, 2017
Feb. 15, 2017
Dec. 31, 2017
Dec. 31, 2016
Jan. 17, 2018
Jan. 30, 2017
Acquisitions (Textual)                      
Ownership interest percentage               20.00%      
Revenue               $ 890,258    
Net loss               (39,037,489) (17,691,060)    
Fair value of common stock               $ 1,251,000    
Common stock, par value               $ 0.025 $ 0.025    
Discount trading price of stock               10.00%      
Impairment expense               $ 221,146    
Warrants exercise price, per share               $ 1.06      
Exercise price                     $ 22.40
Aggregate issuance of common stock value               $ 1,032,000      
Underwriting agreement, description               Pursuant to the Underwriting Agreement, the Company granted the Underwriters a 45-day option to purchase up to an additional 300,000 shares of Common Stock and/or 75,000 Warrants to purchase shares of Common Stock with an exercise price of $1.90 per share.      
Shares issued of common stock     1,083,017     2,000,000   3,000,000      
American Science and Technology Corporation [Member]                      
Acquisitions (Textual)                      
License patent term 24 months                    
Underwriting agreement, description

The Patent License Agreement, on January 1, 2018, the Company will pay to AST $200,000 and the Company will issue to AST 200,000 shares of the Company’s common stock, and, beginning effective January 1, 2019, the Company will pay to AST a monthly license fee of $50,000. Pursuant to the commercial lease, on January 1, 2018, the Company will pay to AST $300,000 and the Company will issue to AST 300,000 shares of the Company’s restricted common stock, and, beginning effective January 1, 2019, the Company will pay to AST a monthly rent of $75,000. Pursuant to these agreements, the Company and AST also entered into an Option Agreement (the “Option”), granting the Company the option to purchase the assets of AST for $2,500,000, in addition to certain royalty and other future payments.

 

Under these arrangements, the Company paid $500,000 to AST during 2017 (comprising of the required $200,000 and $300,000 payments cited above, respectively).

                   
Subsequent Event [Member]                      
Acquisitions (Textual)                      
Stock price                   $ 0.025  
Minimum [Member]                      
Acquisitions (Textual)                      
Stock price                     0.00
Maximum [Member]                      
Acquisitions (Textual)                      
Stock price                     $ 6.20
CFS Group, LLC [Member]                      
Acquisitions (Textual)                      
Ownership interest percentage             100.00%        
Restricted shares of common stock             500,000        
Fair value of common stock             $ 1,251,000        
Discount trading price of stock             10.00%        
Mobile Science Technologies, Inc. [Member]                      
Acquisitions (Textual)                      
Share exchange agreement, description     In the Share Exchange Agreement, 403,864 of the Purchase Shares were issued as of the closing date, with the remaining 679,153 Purchase Shares to be issued upon certain milestones.                
Exchange shares of common stock     1,083,017                
Number of shares purchased     28,333,333                
Shares issued and outstanding, description     Prior to its entering into the Share Exchange Agreement, the Company owned 5,000,000 shares of MSTI, or 15% of the issued and outstanding stock of MSTI, which was accounted for as an equity method investment. Originally, the Company transferred the assets of MSTI for its initial 15% investment, and then repurchased those assets with additional shares of stock of the Company. As a result of the closing of the Share Exchange Agreement the Company became the owner of 100% of the shares of MSTI.                
Impairment expense           $ 221,146          
Outstanding stock purchased, percentage     100.00%                
DxT Medical, LLC [Member]                      
Acquisitions (Textual)                      
Ownership interest percentage         100.00%            
Restricted shares of common stock         350,000            
Revenue               $ 0      
Net loss               $ 390,000      
Fair value of common stock         $ 318,500            
Common stock, par value         $ 0.025            
WelNess Benefits, LLC/Integrity Lab Solutions, LLC [Member]                      
Acquisitions (Textual)                      
Ownership interest percentage   100.00%                  
Shares issued and outstanding, description   WelNess owns 71.64% membership interest in LGMG, LLC d/b/a Verifi Resource Group.                  
Purchase agreement, description   The Purchase Agreement provides for an earn-out opportunity, payable in cash to the sellers on the sixtieth (60th) day after the first anniversary of the Closing Date, and again on the sixtieth (60th) day after second anniversary of Closing Date, each equal to twenty five percent (25%) of the combined earnings before interest, taxes and depreciation, excluding Accounts Receivables and capital expenditures, of the Operating Companies (as defined in the Purchase Agreement) (the "CA EBITDA") for the immediately preceding 12-month period ending on October 31 of such year. On the sixtieth (60th) day after the third full anniversary of the Closing, the Buyer shall pay a cash bonus (the "Third Year Cash Bonus") to Sellers equal twenty five percent (25%) of the combined earnings before interest, taxes and depreciation, excluding Accounts Receivables which are more than 120 days old and capital expenditures, of the Operating Companies (the "Last Year CA EBITDA") for immediately preceding 12-month period ending on October 31 of such year.                  
Earnout payment, description   (i) on the ninetieth (90th) day after first anniversary of the Closing ("First Anniversary Earnout Payment Date"), Tranche III Shares in the amount equal to 500% of the CA EBITDA for the immediately preceding 12-month period ending on October 31 of such year, less the amount of the cash bonus paid on the First Bonus Payment Date, if any; and (ii) on the ninetieth (90th) day after the second, third, fourth, and fifth anniversaries of the Closing (each an "Anniversary Earnout Payment Date"), Tranche III Shares in the amount equal to the product of the Applicable Year Multiplier (as hereinafter defined) multiplied by the difference between the CA EBITDA for the immediately preceding 12-month period ending on October 31 of such year, less the amount of the applicable cash bonus, if any, paid on the immediately preceding Bonus Payment Date, (the "Adjusted CA EBITDA") and less (x) the previous year's Adjusted CA EBITDA on the second and third Anniversary Earnout Payment Date, or (y) the previous year's CA EBITDA on the fourth and fifth Anniversary Earnout Payment Date.                  
Warrants to purchase shares of common stock   1,000,000                  
Term of warrants   5 years                  
Operating expenses totaling   $ 60,000                  
Warrants exercise price, per share   $ 1.00                  
Stock consideration   1,000,000                  
Restricted common shares   1,000,000                  
WelNess Benefits, LLC/Integrity Lab Solutions, LLC [Member] | Contingent consideration [Member]                      
Acquisitions (Textual)                      
Estimated volatility   143.46%                  
Stock consideration   1,000,000                  
Stock price   $ 1.00                  
Risk-free interest rate   2.01%                  
WelNess Benefits, LLC/Integrity Lab Solutions, LLC [Member] | Warrant Consideration [Member]                      
Acquisitions (Textual)                      
Estimated volatility   143.00%                  
Stock price   $ 1.00                  
Risk-free interest rate   2.01%                  
Exercise price   $ 1.00                  
Term   5 years                  
Shares issued of common stock   2,031,000                  
WelNess Benefits, LLC/Integrity Lab Solutions, LLC [Member] | Contingent Consideration Initially and Subsequently Fair Value [Member]                      
Acquisitions (Textual)                      
Estimated volatility               157.53%      
Stock price               $ 1.06      
Risk-free interest rate               2.20%      
Fair value of acquisition               $ 1,900,000      
Shares issued of common stock               1,605,000      
WelNess Benefits, LLC/Integrity Lab Solutions, LLC [Member] | Minimum [Member] | Contingent consideration [Member]                      
Acquisitions (Textual)                      
Term   1 year                  
WelNess Benefits, LLC/Integrity Lab Solutions, LLC [Member] | Minimum [Member] | Contingent Consideration Initially and Subsequently Fair Value [Member]                      
Acquisitions (Textual)                      
Term               1 year      
WelNess Benefits, LLC/Integrity Lab Solutions, LLC [Member] | Maximum [Member] | Contingent consideration [Member]                      
Acquisitions (Textual)                      
Term   5 years                  
WelNess Benefits, LLC/Integrity Lab Solutions, LLC [Member] | Maximum [Member] | Contingent Consideration Initially and Subsequently Fair Value [Member]                      
Acquisitions (Textual)                      
Term               5 years      
Advanced Lignin Biocomposites, LLC [Member]                      
Acquisitions (Textual)                      
Estimated volatility       152.15%       135.99%      
Stock price       $ 1.29       $ 1.06      
Risk-free interest rate       1.61%       1.76%      
Term       1 year       10 months 17 days      
Aggregate issuance of common stock value       $ 1,032,000              
Aggregate issuance of common stock shares       800,000              
Fair value of acquisition       $ 2,100,000       $ 2,300,000      
Gross proceeds of per share       $ 4.00